GACM Technologies Limited (BOM:531723)

Verve Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	8.48	10.48	8.43	8.56	9.48
Accounts Receivable	-	160.54	68.77	14.05	0.38	23.03
Other Receivables	-	-	0.05	2.55	13.22	4.42
Property, Plant & Equipment	-	17.1	9.12	12.43	12.21	3.14
Other Intangible Assets	-	165.23	1.76	5.83	9.54	0.08
Investments in Debt & Equity Securities	-	68	-	-	-	-
Other Current Assets	-	27.21	19.34	27.62	17.48	29.21
Long-Term Deferred Tax Assets	-	-	0.02	-	-	-
Other Long-Term Assets	-	217.02	74.9	59.83	61.33	28.72
Total Assets	-	663.57	184.44	130.73	122.72	98.08
Accounts Payable	-	3.79	-	21.07	-	3.16
Accrued Expenses	-	0.54	21.81	2.42	9.85	3.99
Other Current Liabilities	-	36.54	1.07	1.22	5.09	31.68
Long-Term Debt	-	-	88.49	172.03	167.43	38.66
Long-Term Deferred Tax Liabilities	-	0.85	-	0.01	-	-
Other Long-Term Liabilities	-	125.39	-	-	-	-
Total Liabilities	-	167.11	113.12	196.87	182.52	77.49
Common Stock	-	798.79	399.4	287.06	286.26	286.26
Additional Paid-In Capital	-	-	296.94	283.16	278.53	278.53
Retained Earnings	-	-	-625.02	-636.36	-624.59	-544.2
Comprehensive Income & Other	-	-302.33	-	-	-	-
Total Common Equity	496.46	496.46	71.32	-66.14	-59.8	20.59
Shareholders' Equity	496.46	496.46	71.32	-66.14	-59.8	20.59
Total Liabilities & Equity	-	663.57	184.44	130.73	122.72	98.08
Total Debt	-	-	88.49	172.03	167.43	38.66
Net Cash (Debt)	8.48	8.48	-78.01	-163.6	-158.87	-29.17
Net Cash Per Share	0.01	0.01	-0.20	-0.57	-0.55	-0.10
Filing Date Shares Outstanding	890.93	629.35	739.68	287.06	229.01	229.01
Total Common Shares Outstanding	890.93	629.35	399.4	287.06	229.01	229.01
Working Capital	-	155.36	74	27.81	24.55	27.31
Book Value Per Share	0.79	0.79	0.18	-0.23	-0.26	0.09
Tangible Book Value	331.23	331.23	69.56	-71.97	-69.34	20.51
Tangible Book Value Per Share	0.53	0.53	0.17	-0.25	-0.30	0.09

Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.